Prevalence of depressive disorders in Parkinson's disease at the University Neurology Clinic of National University Teaching Hospital Hubert Koutoukou Maga, Cotonou, 2024
East African Journal of Neurological Sciences · 2026 · 5 (4) · 193-201
DOI: 10.4314/eajns.v5i4.2 ↗Abstract
Background: Neurodegenerative diseases, such as Parkinson's disease (PD), occupy a central place in global public health. The impact of neuropsychiatric disorders like depression and anxiety on a patient's quality of life is well-documented. However, they are under-identified in Africa and Benin due to cultural taboos and limited access to mental health services. Objective: To evaluate the prevalence of depressive disorders in Parkinson's disease patients at the University Neurology Clinic of the National University Teaching Hospital Hubert Koutoukou Maga in Cotonou in 2024. Methods: Patients were retrospectively identified from records between 2015 and 2024 and then assessed cross-sectionally in 2024. The Hospital Anxiety and Depression Scale (HADS) was used to differentiate depressive disorders, alongside a range of general and PD-related clinical characteristics. Results: A total of 122 cases of Parkinson's disease (PD) were identified, and 42 were included in the study, comprising 36 men and 6 women with a mean age of 59.69 ± 12.18 years. Depression was found in 30.95% of PD patients, with 21.43% experiencing mild depression, 7.14% moderate depression, and 2.38% severe depression. Factors associated with depression included non-motor symptoms, advanced disease stage according to the Hysterical & Young (H&Y) classification, loss of independence, and impairment in all dimensions of quality of life (except social support). Conclusion: This study revealed a significant prevalence of depressive disorders in Parkinson's disease patients in our region, highlighting their considerable impact on patients' quality of life. These results advocate for a multidisciplinary approach to improve their quality of life.
EUVIMED